David Krempa

Insider Reports History

Location
Deer Park, IL
Signature
/s/ James R. Gruber
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Krempa:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eton Pharmaceuticals, Inc. Chief Business Officer Common Stock 630,238 $9,844,317 $15.62 14 Jan 2026 Direct
Eton Pharmaceuticals, Inc. Chief Business Officer Restricted Stock Units 696,749 $206,527 $7.98 12 Jan 2026 Direct
Eton Pharmaceuticals, Inc. Chief Business Officer Employee Stock Option (Right to Buy) 670,893 12 Jan 2026 Direct

Insider Reports Filed by David Krempa

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ETON Eton Pharmaceuticals, Inc. 12 Jan 2026 3 -$30,334 4 Chief Business Officer 14 Jan 2026, 18:03
ETON Eton Pharmaceuticals, Inc. 11 Dec 2025 2 -$106,488 4 Chief Business Officer 12 Dec 2025, 16:56
ETON Eton Pharmaceuticals, Inc. 12 Jun 2025 3 -$504,318 4 Chief Business Officer 16 Jun 2025, 16:56
ETON Eton Pharmaceuticals, Inc. 03 Jan 2025 2 $0 4 Chief Business Officer 06 Jan 2025, 16:16
ETON Eton Pharmaceuticals, Inc. 02 Oct 2024 1 $0 4 Chief Business Officer 04 Oct 2024, 16:19
ETON Eton Pharmaceuticals, Inc. 13 Feb 2024 1 $0 4 Chief Business Officer 15 Feb 2024, 16:17
ETON Eton Pharmaceuticals, Inc. 01 Mar 2023 0 $0 3 Chief Business Officer 08 Mar 2023, 13:39